These final results, along with a prior report showing that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 support the principle of targeting ACKR3 as a singular solution to modulate the opioid program, which could open new therapeutic avenues for opioid-associated Diseases. Chronic ache is complex, and https://elizabethz058rli7.azzablog.com/profile